Patients with JIA-associated uveitis who discontinued adalimumab had higher recurrence rates than those who continued the ...

The patient has iMCD, which has a poor survival rate and few treatment options but an AI tool searched through 4,000 ...

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a ...

The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key assets underway: olanzapine for treatment of schizophrenia, ...

Researchers used an AI-driven approach to identify adalimumab as a potential life-saving treatment for idiopathic ...

UBS forecasts that Sandoz will likely achieve the lower end of its 24-26% core EBITDA margin target by 2028. To reach the ...

Teaser: Off-label systemic agents may treat inflammatory autoimmune vulvar diseases such as lichen sclerosus and lichen ...

While you wait for the groundhog to make his determination this weekend, take some time to buff up your knowledge of ...